Skip to main content
. 2021 Sep 8;8:695195. doi: 10.3389/fmed.2021.695195

Table 1.

Demographic, clinical, laboratory findings of patients on admission.

All Mild/moderate disease Severe/critical disease p
Total sample, N° (%) 171 (100%) 134 (78.47%) 37 (21.63%)
Age years, mean (SD) 64.91 (13.59) 61.69 (13.21) 76.65 (6.93) 0.001
Male patients, N° (%) 136 (79.53%) 102 (76.11%) 34 (91.89%) 0.021
Smoking history, N° (%) 39 (22.83%) 28 (20.89%) 11 (29.72%) 0.039
Body Mass Index, kg/m2, mean (SD) 25.58 (3.85) 24.31 (3.97) 27.55 (3.21) 0.041
Charlson Comorbidity Index, mean (SD) 3.37 (2.21) 2.72 (1.69) 5.72 (2.28) 0.001
Signs and symptoms on admission
Days from first symptoms, mean (SD) 6.3 (4.92) 5.1 (3.92) 7.4 (3.22) 0.034
Fever ≥ 38.8°C, N° (%) 120 (70.21%) 93 (69.4%) 27 (74.41%) 0.176
Dry cough, N° (%) 108 (63.15%) 85 (63.4%) 23 (62.21%) 0.784
Fatigue, N° (%) 102 (59.64%) 79 (58.95%) 23 (62.16%) 0.482
Myalgia, N° (%) 86 (50.29%) 66 (49.25%) 20 (54.05%) 0.091
Anosmia, N° (%) 67 (39.18%) 51 (38.305%) 15 (40.54%) 0.599
Dyspnea, N° (%) 63 (36.84%) 47 (35.07%) 16 (43.24%) 0.058
Borg dyspnea index, mean (SD) 2.61 (1.57) 2.07 (1.61) 3.25 (1.44) 0.025
Laboratory findings
C-Reactive protein, mg/L, mean (SD) 11.28 (13.75) 9.40 (13.65) 11.87 (14.26) 0.046
Computed tomography findings
Ground-glass opacity, N° (%) 140 (81.87%) 110 (82.15%) 30 (81.11%) 0.768
Consolidation, N° (%) 122 (71.34%) 93 (69.41%) 29 (78.42%) 0.031
Interlobular septal thickening, N° (%) 78 (45.61%) 49 (36.56%) 29 (78.37%) 0.005
Reticular opacity, N° (%) 76 (44.44%) 50 (37.31%) 26 (70.27%) 0.009
Air bronchogram, N° (%) 69 (40.35%) 46 (34.32%) 23 (62.16%) 0.021
Crazy-paving pattern, N° (%) 35 (20.54%) 24 (17.91%) 11 (29.72%) 0.023
Lymph node enlargement, N° (%) 25 (14.61%) 20 (14.92%) 5 (13.51%) 0.679
Pericardial effusion, N° (%) 16 (9.35%) 11 (8.21%) 5 (13.51%) 0.066
Pleural effusion, N° (%) 14 (8.18%) 10 (7.46%) 4 (10.81%) 0.054
Lung computed tomography severity score, mean (SD) 64.91 (13.59) 61.69 (13.21) 76.65 (6.93) 0.001

SD, standard deviation.